Literature DB >> 4933388

Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia.

A N Howard, D E Hyams.   

Abstract

A comparison was made of the effect of DEAE (diethylaminoethyl) Sephadex (an anion exchange resin) and cholestyramine (Questran) with and without the addition of clofibrate in normal and hypercholesterolaemic patients. DEAE Sephadex (12-15 g/day) alone appeared to be as effective as cholestyramine in lowering the plasma cholesterol by 12-15%. Clofibrate acted synergistically with DEAE Sephadex and increased the activity of the latter by over twofold. This combination proved superior to that of clofibrate and cholestyramine and has the greatest potential use in the treatment of type II pattern hyperlipoproteinaemia.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4933388      PMCID: PMC1800097          DOI: 10.1136/bmj.3.5765.25

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  A SEMIAUTOMATED PROCEDURE FOR THE DETERMINATION OF TRIGLYCERIDES IN SERUM.

Authors:  H B LOFLAND
Journal:  Anal Biochem       Date:  1964-12       Impact factor: 3.365

2.  CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.

Authors:  S A HASHIM; T B VANITALLIE
Journal:  JAMA       Date:  1965-04-26       Impact factor: 56.272

3.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

Review 4.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-19       Impact factor: 91.245

5.  Hypolipidemic effects of orally administered dextran and cellulose anion exchangers in cockerels and dogs.

Authors:  T M Parkinson
Journal:  J Lipid Res       Date:  1967-01       Impact factor: 5.922

6.  Turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

  6 in total
  4 in total

1.  Treatment of hyperlipoproteinaemia type II A with a new anion exchange resin secholex.

Authors:  A Gustafson; A Lanner
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 2.  Hypolipaemic drugs and coronary heart disease.

Authors:  A N Howard
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

3.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01

4.  Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.

Authors:  R Houlston; J Quiney; G F Watts; B Lewis
Journal:  J R Soc Med       Date:  1988-05       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.